Jean-Francois Formela
Director at Antares Therapeutics.
Raised on Antares Therapeutics filings
$70M
of $176.7M offered across 2 Form D filings
- Form D filings
- 2
- Teammates
- 7
- Last filing
- May 15, 2025
Company
Antares Therapeutics
Healthcare · Boston, MA
Leading specialty pharmaceutical company focused on the creation and commercialization of innovative drug delivery technologies
Leading specialty pharmaceutical company focused on the creation and commercialization of innovative drug delivery technologies
- Investors
- 3
- Founded
- 2025
- Still open
- $106.7M
Antares Therapeutics filings
| Filed | Security | Sold of offered | Filing |
|---|---|---|---|
| May 15, 2025 | Equity | $30M/ $136.7M | Form D |
| Mar 12, 2025 | Security to be acquired | $40M/ $40M | Form D |
